Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR

被引：0
|
作者：
Welte, T. [1 ]
Menzies-Gow, A. [2 ]
Israel, E. [3 ]
Corren, J. [4 ]
Hunter, G. [5 ]
Cook, W. [6 ]
Colice, G. [5 ]
Lanos-Ackert, P. J. [7 ]
机构：
[1] Hannover Med Sch, Klin Pneumol, D-30625 Hannover, Germany
[2] Royal Brompton Hosp London, Resp Med, London, England
[3] Arvard Med Sch Boston, Boston, MA USA
[4] Univ Calif, David Geffen Sch Med, Davis, CA USA
[5] Astrazeneca, Cambridge, England
[6] Astrazeneca, Biopharmaceut Med, Resp & Immunol, Cambridge, England
[7] Amgen Inc, Global Med Affairs, Thousand Oaks, CA USA
来源：
PNEUMOLOGIE | 2022年 / 76卷
关键词：
D O I：
10.1055/s-0042-1747712
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Po 88
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [41] Tezepelumab for Patients with uncontrolled Asthma
    Krome, Susanne
    PNEUMOLOGIE, 2021, 75 (12):
  • [42] On-treatment clinical remission with tezepelumab among patients with severe, uncontrolled asthma in the phase 3 NAVIGATOR study
    Castro, M.
    Ambrose, C. S.
    Colice, G.
    Roseti, S. L.
    Kmita, K.
    Cook, B.
    Martin, N.
    Llanos-Ackert, J.
    Menzies-Gow, A.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [43] REDES Study: Mepolizumab Is Effective in Patients With Severe Asthma and Comorbid Nasal Polyps
    Arismendi, E.
    Cisneros, C.
    Blanco-Aparicio, M.
    Martinez-Moragon, E.
    Quirce, S.
    Conejero, D. Banas
    Lopez-Moure, A.
    Sanchez-Herrero, M. G.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2023, 33 (06) : 476 - 479
  • [44] Efficacy Of Mepolizumab In Patients With Severe Eosinophilic Asthma And Nasal Polyps
    Liu, Mark C.
    Keene, Oliver N.
    Yancey, Steven W.
    Bratton, Daniel J.
    Albers, Frank C.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB8 - AB8
  • [45] Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma
    Menzies-Gow, Andrew
    Corren, Jonathan
    Bourdin, Arnaud
    Chupp, Geoffrey
    Israel, Elliot
    Wechsler, Michael E.
    Brightling, Christopher E.
    Griffiths, Janet M.
    Hellqvist, Asa
    Bowen, Karin
    Kaur, Primal
    Almqvist, Gun
    Ponnarambil, Sandhia
    Colice, Gene
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (19): : 1800 - 1809
  • [46] Effects of tezepelumab on asthma exacerbations, type 2 biomarkers, lung function and asthma control in patients with severe, uncontrolled asthma with and without nasal polyps: PATHWAY phase IIb study
    Emson, C.
    Corren, J.
    Salapa, K.
    Hellqvist, A.
    Parnes, J. R.
    Colice, G.
    ALLERGY, 2020, 75 : 19 - 20
  • [47] Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study
    Corren, Jonathan
    Ambrose, Christopher S. S.
    Griffiths, Janet M. M.
    Hellqvist, Asa
    Lindsley, Andrew W. W.
    Llanos, Jean-Pierre
    Colice, Gene
    Menzies-Gow, Andrew
    CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (04): : 417 - 428
  • [48] Efficacy Of Tezepelumab In Patients With Severe, Uncontrolled Asthma By Specific Perennial Allergen Immunoglobulin E Thresholds
    Lindsley, Andrew
    Colice, Gene
    Martin, Neil
    Spahn, Joseph
    Martin, Nicole
    Ambrose, Chris
    Hoyte, Flavia
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB18 - AB18
  • [49] Efficacy of tezepelumab in patients with severe, uncontrolled asthma, according to baseline blood eosinophil count and allergic status: results from the phase 3 NAVIGATOR study
    Menzies-Gow, A.
    Corren, J.
    Cook, B.
    Kmita, K.
    Llanos-Ackert, J.
    Colice, G.
    Ambrose, C. S.
    ALLERGY, 2021, 76 : 21 - 22
  • [50] Tezepelumab in Adults and Adolescents with severe, uncontrolled Asthma
    不详
    ALLERGOLOGIE, 2021, 44 (08) : 577 - 578
12345